November 8, 2019 / 10:31 PM / 6 days ago

Incyte unlawfully marketed cancer drug Jakafi says whistleblower lawsuit

Biopharmaceutical company Incyte Corp has engaged in a series of unlawful marketing and kickback schemes aimed at promoting the sale of its blockbuster bone marrow cancer drug Jakafi, a newly unsealed whistleblower lawsuit alleges.

The allegations were detailed in a lawsuit filed in 2018 by a former Incyte executive in federal court in Philadelphia. The U.S. Justice Department is investigating the claims and has not decided whether to join the case, according to court records.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below